protein sub-unit, fibrinogen assay (factor I), high molecular weight kininogen (HMWK), multiple coagulation factor, von Willebrand factor: collagen binding activity (vWF:CBA), von Willebrand factor: ristocetin cofactor complex activity (vWF:RCO). L2CT CT1248 IVDs 2 & 3 IVDs that are intended IVDs) to be used alone or in combination with other IVDs to perform various tests and procedures Calcium chloride. L2CT CT875 Fibrinolysis (Class IVDs 2 & 3 IVDs that are intended IVDs) to be used in testing to provide information about fibrinolysis, fibrin degradation products and components involved in the process of clot breakdown. Alpha-2-antiplasmin, aprotinin, D-dimer, fibrinogen degradation product (FDP), plasmin, complex (PAP), plasminogen activator inhibitor, plasminogen, soluble fibrin monomer complex, thrombin activating fibrinolysis inhibitor, tissue plasminogen activator, total degradation product (TDP), urokinase plasminogen activator. General coagulation IVDs IVDs (Class that are intended 2 & 3 to be used in testing to IVDs) provide information about the general coagulation of blood and the time taken for a clinical blood specimen to clot following initiation of the intrinsic and/or
protein sub-unit, fibrinogen assay (factor I), high molecular weight kininogen (HMWK), multiple coagulation factor, von Willebrand factor: collagen binding activity (vWF:CBA), von Willebrand factor: ristocetin cofactor complex activity (vWF:RCO). L2CT 2 & 3 IVDs) CT1248 IVDs IVDs that are intended to be used alone or in combination with other IVDs to perform various tests and procedures Calcium chloride. L2CT (Class 2 & 3 IVDs) CT875 Fibrinolysis IVDs IVDs that are intended to be used in testing to provide information about fibrinolysis, fibrin degradation products and components involved in the process of clot breakdown. Alpha-2-antiplasmin, aprotinin, D-dimer, fibrinogen degradation product (FDP), plasmin, complex (PAP), plasminogen activator inhibitor, plasminogen, soluble fibrin monomer complex, thrombin activating fibrinolysis inhibitor, tissue plasminogen activator, total degradation product (TDP), urokinase plasminogen activator. (Class 2 & 3 IVDs) General coagulation IVDs IVDs that are intended to be used in testing to provide information about the general coagulation of blood and the time taken for a clinical blood specimen to clot following initiation of the intrinsic and/or
ivd-gmdncodes.docx